Abstract
The precision of charged particle therapy dose deposition is its main advantage to conventional radiotherapy and its weakness when encountering range uncertainties in clinical practice. We offer a new perspective on treatment verification by introducing a technique to estimate electronic stopping power during the treatment from the measurement of time between particle target entry and prompt gamma detection (TOF-ULET). For the estimation of electronic stopping power, we developed a lightweight analytical model for axial particle motion inside the patient. We used Monte Carlo simulations of a homogenous PMMA phantom as a first test of our method, achieving ~ 6 % estimation errors for 170 MeV and 189 MeV protons. The in-beam estimation of electronic stopping power opens up new opportunities in treatment adaptation between fractions by not only indicating significant deviations from the treatment plan, but also offering a current estimate of the patients' anatomy along the beam path and - using conversion models - the delivered dose.
| Original language | English |
|---|---|
| Title of host publication | 2022 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) |
| Publication date | 26.01.2024 |
| DOIs | |
| Publication status | Published - 26.01.2024 |
| Event | 2022 IEEE Nuclear Science Symposium and Medical Imaging Conference - Milan, Italy Duration: 05.11.2022 → 12.11.2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 9 Industry, Innovation, and Infrastructure
Research Areas and Centers
- Academic Focus: Biomedical Engineering
- Centers: Center of Imaging Sciences (CIS)
DFG Research Classification Scheme
- 2.22-32 Medical Physics, Biomedical Technology
Prizes
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver